Company Coverage
TA: Kingsoft Corporation (3888 HK) / Hansoh Pharmaceutical Group (3692 HK)
Analyst


Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at the following link: https://research-api.uobkayhian.com/assets/disclaimer/0e6d602f-adeb-45f8-9dea-5d5591daae87, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
Related articles
Our latest research
28 Oct 2026
TA: Swire Properties (1972 HK) / CK Hutchison (0001 HK)

28 Oct 2026
Huizhou Desay SV (002920 CH): 3Q26: Revenue Growth Accelerates To 24%, But Earnings Miss On Subsidy Cuts, Credit Provisions, Associates’ Losses, And Tax Hikes

28 Oct 2026
